Clinical Nuclear Medicine

Skip Navigation LinksHome > January 2014 - Volume 39 - Issue 1 > Predictive Value of 68Ga-DOTANOC PET/CT in Patients With Sus...
Clinical Nuclear Medicine:
doi: 10.1097/RLU.0000000000000257
Original Articles

Predictive Value of 68Ga-DOTANOC PET/CT in Patients With Suspicion of Neuroendocrine Tumors: Is Its Routine Use Justified?

Sharma, Punit MD*; Arora, Saurabh MBBS*; Mukherjee, Anirban MBBS*; Pal, Sujoy MS; Sahni, Peush MS; Garg, Pramod DM; Khadgawat, Rajesh DM§; Thulkar, Sanjay MD; Bal, Chandrasekhar MD*; Kumar, Rakesh PhD*

Collapse Box


Objective: The objective of this study was to evaluate the predictive value of 68Ga-DOTANOC PET/CT in patients with suspected neuroendocrine tumor (NET).

Methods: Data of 164 patients (mean age, 42.5 ± 17.3 years; 54.8% male) who underwent 68Ga-DOTANOC PET/CT for suspected NET were retrospectively analyzed. Neuroendocrine tumor was suspected based on clinical features (n = 94) and/or raised biochemical markers (n = 83, serum chromogranin A, gastrin, serum/urinary catecholamines, insulin/C-peptide, and 5-hydroxytrytophan/5-hydroxyindoleacetic acid) and/or imaging findings (n = 93). PET/CT images were reviewed by 2 experienced nuclear medicine physicians, and any nonphysiological 68Ga-DOTANOC uptake was taken as positive for NET. Histopathology (n = 55) and clinical/imaging follow-up (n = 109; median, 11 months) was used as reference standard.

Results: Based on the reference standard, 97 of 164 patients had NET. 68Ga-DOTANOC PET/CT was positive for NET in 101 and negative in 63 patients. Primary tumor was demonstrated in 90 patients (commonest site—pancreas) and metastasis in 30 (commonest site—liver). PET/CT was true positive in 92 patients, true negative in 58, false positive in 9, and false negative in 5. The overall sensitivity was 94.8%, specificity was 86.5%, positive predictive value was 91%, negative predictive value was 92%, and accuracy was 91.4%. The accuracy of PET-CT in patients with clinical features of NET was 90.4%, with raised biochemical markers was 86.7%, and with imaging findings suggestive of NET was 93.5%. No difference was seen in the accuracy in patients with or without clinical symptoms (P = 0.794), raised versus those with normal/unknown biochemical markers (P = 0.094), and suggestive imaging versus those with negative/unavailable imaging (P = 0.420).

Conclusions: 68Ga-DOTANOC PET-CT shows high positive and negative predictive values in patients with suspected NET and can be routinely used for this purpose.

© 2014 by Lippincott Williams & Wilkins


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.